We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
-14.03%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22.9B
AUM Growth
-$4.32B
Cap. Flow
-$424M
Cap. Flow %
-1.85%
Top 10 Hldgs %
13.89%
Holding
1,428
New
104
Increased
438
Reduced
568
Closed
134

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$499M
2
BMY icon
Bristol-Myers Squibb
BMY
+$59.2M
3
HUM icon
Humana
HUM
+$54.1M
4
EMR icon
Emerson Electric
EMR
+$47.7M
5
TGT icon
Target
TGT
+$45.5M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$68.5M
2
SYK icon
Stryker
SYK
+$50.3M
3
JNJ icon
Johnson & Johnson
JNJ
+$46.2M
4
NVDA icon
NVIDIA
NVDA
+$44.1M
5
SWK icon
Stanley Black & Decker
SWK
+$40.5M

Sector Composition

Rank Sector Weight
1 Technology 21.77%
2 Healthcare 16.07%
3 Financials 11.39%
4 Consumer Discretionary 9.78%
5 Industrials 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JLL icon
826
Jones Lang LaSalle
JLL
$15.7B
$1.82M 0.01%
14,383
+1,800
+14% +$243K
REG icon
827
Regency Centers
REG
$13.6B
$1.81M 0.01%
+30,898
New +$1.93M
TSN icon
828
Tyson Foods
TSN
$18.5B
$1.77M 0.01%
33,241
-7,500
-18% -$441K
GWW icon
829
W.W. Grainger
GWW
$59.8B
$1.74M 0.01%
6,171
+5,000
+427% +$1.49M
ARW icon
830
Arrow Electronics
ARW
$10.8B
$1.73M 0.01%
+25,065
New +$1.78M
GG
831
DELISTED
Goldcorp Inc
GG
$1.72M 0.01%
175,843
+5,524
+3% +$53.6K
AMN icon
832
AMN Healthcare
AMN
$1.32B
$1.71M 0.01%
30,100
-40,100
-57% -$2.25M
VRA icon
833
Vera Bradley
VRA
$116M
$1.69M 0.01%
197,099
-7,500
-4% -$88.1K
WTW icon
834
Willis Towers Watson
WTW
$29.9B
$1.68M 0.01%
11,041
+4,000
+57% +$599K
IBN icon
835
ICICI Bank
IBN
$102B
$1.67M 0.01%
161,999
-500,037
-76% -$4.72M
M icon
836
Macy's
M
$5.77B
$1.66M 0.01%
55,777
+42,600
+323% +$1.4M
AROC icon
837
Archrock
AROC
$5.36B
$1.66M 0.01%
+221,000
New +$2.24M
BFYT
838
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$1.65M 0.01%
+61,800
New +$2.48M
FITB
839
Fifth Third Bancorp
FITB
$49.6B
$1.65M 0.01%
70,160
-33,700
-32% -$887K
FHN icon
840
First Horizon
FHN
$11.6B
$1.64M 0.01%
124,900
-10,100
-7% -$157K
DLR icon
841
Digital Realty Trust
DLR
$66.5B
$1.64M 0.01%
15,414
+850
+6% +$93.9K
BPMC
842
DELISTED
Blueprint Medicines
BPMC
$1.64M 0.01%
30,404
NXGN
843
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
$1.64M 0.01%
107,954
-38,546
-26% -$661K
TLT icon
844
iShares 20+ Year Treasury Bond ETF
TLT
$46.4B
$1.62M 0.01%
13,331
+6,946
+109% +$804K
IPG
845
DELISTED
Interpublic Group of Companies
IPG
$1.61M 0.01%
78,295
+48,300
+161% +$1.1M
QDEL icon
846
QuidelOrtho
QDEL
$729M
$1.61M 0.01%
32,900
+19,300
+142% +$1.15M
CMBT
847
CMB.TECH NV
CMBT
$5.68B
$1.6M 0.01%
230,742
ADMS
848
DELISTED
Adamas Pharmaceuticals
ADMS
$1.59M 0.01%
185,977
-4,853
-3% -$63.1K
PEN icon
849
Penumbra
PEN
$12.5B
$1.58M 0.01%
12,900
+9,600
+291% +$1.29M
OLP
850
One Liberty Properties
OLP
$505M
$1.56M 0.01%
64,396
-15,078
-19% -$390K

Similar funds

Axa's Q4 2018 Portfolio in Review

As of Q4 2018, Axa held 1,428 positions worth $22.9B, down 16% from $27.3B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Axa's Q4 2018 filing shows 104 new, 438 increased, 568 reduced and 134 closed positions. Its largest new stake was Linde: 3,157,617 shares worth $493M. The largest sale was Hologic, an estimated $68.5M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Axa's largest Q4 2018 buy was Linde: 3,157,617 shares worth $493M.
  • Axa added most to Bristol-Myers Squibb in Q4 2018, an estimated $59.2M increase.
  • Axa's biggest Q4 2018 reduction was Hologic, cutting an estimated $68.5M.
  • Axa fully exited Praxair Inc in Q4 2018, selling an estimated $25.6M.
  • Axa's ten largest holdings make up 14% of its $22.9B portfolio in Q4 2018.
  • Axa opened 104 new positions and closed 134 in Q4 2018.
  • Axa's portfolio value fell 16% quarter-over-quarter to $22.9B.

Based on Axa's 13F filing for Q4 2018, filed 13 Feb 2019.